Breast Cancer Clinical Trial
Official title:
Bridging the Gap: Incorporating Exercise Evidence Into Clinical Practice in Breast Cancer Care in Ontario
Breast cancer (BC) and its treatments lead to numerous side effects that affect a person's
life for years after treatment has ended. Research shows that regular exercise limits many of
these side effects. However, less than 30% of BC survivors regularly exercise due to many
barriers that include patients being unaware of the benefits of exercise, health
professionals facing institutional, personal, and patient-related barriers to promoting
exercise, and a lack of knowledge translation (KT) strategies within cancer institutions that
focus on accessible exercise interventions and education by physiotherapists. For this
project, a pilot study is needed as the first step in order to assess process and resource
variables before implementation of a large-scale intervention.
The primary objective of this pilot trial is to assess the feasibility of conducting a larger
trial to evaluate the effects of a novel KT intervention using exercise and self-management
versus usual care among BC survivors. The secondary objective is to determine preliminary
estimates of effects of the KT intervention of exercise plus self-management (SM) program
versus usual care on (a) levels of exercise knowledge and behaviour, (b) health related
quality of life and (c) resource utilization, among BC survivors over a four month period.
Study Design: Pilot randomized controlled trial. Eligibility: Women older than 18 years who
are currently undergoing chemotherapy treatment for BC.
Intervention: The intervention group includes an 8-session multi-component intervention with
a structured aerobic exercise program plus SM supervised by a physiotherapist.
Setting: Outpatient-Juravinski Cancer Centre in Hamilton, ON. Control: Usual care.
Randomization: Participants will be randomly allocated using a 1:1 allocation ratio to
receive the intervention of structured exercise plus SM program or usual care.
Sample size: The study will recruit n=12 number of participants/group for a total of 24 in
both groups.
Analysis: A blinded assessor will assess outcomes at baseline, post intervention, at 2- and
4-month follow up. Intervention feasibility and effectiveness will be assessed using
descriptive statistics and analysis of covariance for continuous outcomes.
Anticipated Impact: This study aims to assess the feasibility of a larger trial to determine
effective ways to close the current KT gap and increase exercise awareness for women with BC.
This project will assess process and resource variables before implementation of a larger
scale intervention. Together, the overall project goal is to promote sustainable exercise
behaviour to help manage the burden of BC.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |